Deep Blue BioTech, a leader in cyanobacteria-based biomanufacturing, has closed its pre-seed funding round led by Sustainable Ventures, with contributions from SFC Capital, One Planet Capital, PCS International Limited, and Carbon13. This funding, along with two Innovate UK grants, will help accelerate their mission to create regenerative ingredients using their advanced Cyanobacterial Technology Platform.

Cyanobacteria, which use light and CO₂ as inputs, offer a scalable and eco-friendly alternative to traditional methods. Deep Blue BioTech’s innovative platform addresses key challenges in photosynthetic biomanufacturing, enabling the production of high-value chemicals with reduced costs and a net-positive carbon footprint. The company aims to revolutionise industries such as beauty, personal care, nutrition, and industrial chemicals by providing sustainable solutions that enhance product performance and address climate challenges.

Deep Blue BioTech was created in Cohort 5 of our Venture Builder Programme in Cambridge. Learn more about Deep Blue BioTech here.